{"id":"https://openalex.org/W1970666336","doi":"https://doi.org/10.1002/ijc.25674","title":"Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients","display_name":"Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-12","ids":{"openalex":"https://openalex.org/W1970666336","doi":"https://doi.org/10.1002/ijc.25674","mag":"1970666336","pmid":"https://pubmed.ncbi.nlm.nih.gov/20839259"},"language":"en","primary_location":{"id":"doi:10.1002/ijc.25674","doi":"https://doi.org/10.1002/ijc.25674","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.25674","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1970666336"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hdl.handle.net/2066/97359","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046503436","display_name":"Ingrid M.E. Desar","orcid":"https://orcid.org/0000-0003-0945-8299","observed_orcids":["https://orcid.org/0000-0003-0945-8299"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid M.E. Desar","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042368190","display_name":"Joannes F.M. Jacobs","orcid":"https://orcid.org/0000-0002-6208-6386","observed_orcids":["https://orcid.org/0000-0002-6208-6386"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. (Hans) F.M. Jacobs","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","institution_ids":[]},{"raw_affiliation_string":"Laboratory of Medical Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067356262","display_name":"Christina A. Hulsbergen\u2010vandeKaa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christina A. Hulsbergen\u2010vandeKaa","raw_affiliation_strings":["Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000396669","display_name":"Wim J.G. Oyen","orcid":"https://orcid.org/0000-0001-8235-7078","observed_orcids":["https://orcid.org/0000-0001-8235-7078"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wim J.G. Oyen","raw_affiliation_strings":["Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103099763","display_name":"Peter Mulders","orcid":"https://orcid.org/0000-0001-8562-6106","observed_orcids":["https://orcid.org/0000-0001-8562-6106"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter F.A. Mulders","raw_affiliation_strings":["Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055163903","display_name":"Winette T.A. van der Graaf","orcid":"https://orcid.org/0000-0001-7549-3338","observed_orcids":["https://orcid.org/0000-0001-7549-3338"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Winette T.A. van der Graaf","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015323424","display_name":"Gosse J. Adema","orcid":"https://orcid.org/0000-0002-6750-1665","observed_orcids":["https://orcid.org/0000-0002-6750-1665"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gosse J. Adema","raw_affiliation_strings":["Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032541182","display_name":"Carla M.L. van Herpen","orcid":"https://orcid.org/0000-0001-5130-5451","observed_orcids":["https://orcid.org/0000-0001-5130-5451"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carla M.L. van Herpen","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054219763","display_name":"I. Jolanda M. de Vries","orcid":"https://orcid.org/0000-0002-8653-4040","observed_orcids":["https://orcid.org/0000-0002-8653-4040"]},"institutions":[{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"I. (Jolanda) J.M. de Vries","raw_affiliation_strings":["Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","Department of Pediatric Hemato-Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","Tel.: 0031 24 3617600,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Department of Pediatric Hemato-Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Department of Tumour Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"I.M.E.D., J.F.M.J., V.M.L. van H. and I.J.M. de V contributed equally","institution_ids":[]},{"raw_affiliation_string":"Tel.: 0031 24 3617600,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054219763"],"corresponding_institution_ids":["https://openalex.org/I2802934949"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":4.7903,"has_fulltext":false,"cited_by_count":146,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95802868,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"129","issue":"2","first_page":"507","last_page":"512"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.3865000009536743,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.3865000009536743,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.35499998927116394,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.149399995803833,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":1.0},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8339999914169312},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9340000152587891},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.9449999928474426},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.7860000133514404},{"id":"https://openalex.org/keywords/ascites","display_name":"ascites","score":0.781000018119812},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.9390000104904175},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.9526426792144775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8235991597175598},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.769381046295166},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7039415836334229},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.6988698244094849},{"id":"https://openalex.org/C2778296632","wikidata":"https://www.wikidata.org/wiki/Q1550619","display_name":"Regulatory T cell","level":5,"score":0.5714060068130493},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4524388313293457},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43141084909439087},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.42814701795578003},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.4162503778934479},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41577446460723877},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3776574432849884},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.35687118768692017},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.304601788520813},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.28652358055114746}],"mesh":[{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016246","descriptor_name":"Lymphocytes, Tumor-Infiltrating","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1002/ijc.25674","doi":"https://doi.org/10.1002/ijc.25674","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ijc.25674","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:20839259","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20839259","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/97359","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2066/97359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/97359","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2066/97359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Cancer, 129, 507 - 12","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/97359","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2066/97359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Cancer, 129, 507 - 12","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1567420244","https://openalex.org/W1980241157","https://openalex.org/W1987446429","https://openalex.org/W1987755269","https://openalex.org/W1988635299","https://openalex.org/W2007996777","https://openalex.org/W2053261820","https://openalex.org/W2062936534","https://openalex.org/W2066604995","https://openalex.org/W2069559049","https://openalex.org/W2076819781","https://openalex.org/W2084604753","https://openalex.org/W2091463916","https://openalex.org/W2094435329","https://openalex.org/W2107631420","https://openalex.org/W2115961668","https://openalex.org/W2116576993","https://openalex.org/W2129411754","https://openalex.org/W2131778873","https://openalex.org/W2133484547","https://openalex.org/W2138163780","https://openalex.org/W2150594590","https://openalex.org/W2150678612","https://openalex.org/W2153550772","https://openalex.org/W2155243111","https://openalex.org/W4313324526"],"related_works":["https://openalex.org/W1976617226","https://openalex.org/W2314388990","https://openalex.org/W2592481785","https://openalex.org/W4234764246","https://openalex.org/W2320482250","https://openalex.org/W2324478361","https://openalex.org/W2129411754","https://openalex.org/W2603190446","https://openalex.org/W2521705038","https://openalex.org/W2318548309"],"abstract_inverted_index":{"Tyrosine":[0],"kinase":[1],"inhibitors":[2],"(TKIs)":[3],"as":[4],"sorafenib":[5,36,87,127,157,169],"are":[6],"known":[7],"to":[8,28,101,151],"reduce":[9],"the":[10,19,25,54,81,131,147,153,166,179],"number":[11],"of":[12,35,47,56,71,83,119,133,156,168,181],"immunosuppressive":[13,109],"regulatory":[14,57],"T":[15,58],"cells":[16,59],"(Tregs)":[17],"in":[18,64,94,99,113,170,174],"peripheral":[20],"blood":[21],"and":[22,49,68,78,117],"thereby":[23],"shifting":[24],"immune":[26],"balance":[27],"a":[29],"more":[30],"stimulating":[31],"setting.":[32],"The":[33],"effect":[34,82],"on":[37,91,189],"intratumoural":[38,92],"Tregs":[39,93,110,123,135,182],"is":[40],"unclear":[41],"but":[42],"important":[43,163],"for":[44,165],"future":[45],"combinations":[46],"TKIs":[48],"immunotherapy.":[50,192],"We,":[51],"therefore,":[52],"evaluated":[53],"accumulation":[55,145],"(Tregs,":[60],"defined":[61],"as,":[62],"CD4(+)FoxP3(+)CD25(high)CD127(low)-cells)":[63],"blood,":[65],"ascites,":[66],"metastases":[67,116],"primary":[69,114],"tumours":[70],"patients":[72,96,175],"with":[73,86,97,172,176,186],"renal":[74],"cell":[75],"carcinoma":[76],"(RCC),":[77],"we":[79],"explored":[80],"neoadjuvant":[84],"treatment":[85,128],"400":[88],"mg":[89],"bid":[90],"11":[95],"RCC":[98,104],"comparison":[100],"15":[102],"nontreated":[103],"patients.":[105],"We":[106],"found":[107],"that":[108],"specifically":[111],"accumulate":[112],"tumour,":[115],"ascites":[118],"RCC-patients.":[120],"Tumour":[121],"infiltrating":[122],"were":[124],"functional.":[125],"Neoadjuvant":[126],"significantly":[129],"reduced":[130],"percentage":[132],"tumour-infiltrating":[134],"(mean":[136],"17.3%":[137],"vs.":[138],"28.1%,":[139],"p":[140],"=":[141],"0.046).":[142],"Diminished":[143],"Treg":[144],"at":[146],"tumour":[148],"site":[149],"adds":[150],"explain":[152],"clinical":[154],"effectiveness":[155],"treatment.":[158],"This":[159],"observation":[160],"may":[161],"have":[162],"implications":[164],"use":[167],"combination":[171],"immunotherapy":[173],"RCC,":[177],"since":[178],"depletion":[180],"has":[183],"been":[184],"associated":[185],"enhanced":[187],"responses":[188],"vaccine":[190],"mediated":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1970666336","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
